[Reduction of severe gastro-intestinal complications after the use of celecoxib:evidence available in the literature].
Oms Arias
M
M
Morral Parente
R M
RM
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000068579:Celecoxib; D019317:Evidence-Based Medicine; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D011720:Pyrazoles; D012720:Severity of Illness Index; D013449:Sulfonamides / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib